|
March 6, 2006 Categories: Uncategorized Posted by admin
Angiotech Pharmaceuticals Inc. a fourth-quarter loss of $51.3 million (U.S.) as the company took in less revenue and booked a one-time charge on acquisitions and a licensing agreement.
Full news
|
|
